NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
15.19
-0.17 (-1.11%)
Nov 21, 2024, 11:42 AM EST - Market open
NeoGenomics Employees
NeoGenomics had 2,100 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$306,723
Profits / Employee
-$37,013
Market Cap
1.95B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Evotec SE | 5,061 |
Omnicell | 3,650 |
Astrana Health | 1,800 |
GeneDx Holdings | 1,000 |
Supernus Pharmaceuticals | 652 |
Beam Therapeutics | 436 |
MannKind | 414 |
NEO News
- 2 days ago - NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment - Business Wire
- 7 days ago - Felicia Williams Joins NeoGenomics Board of Directors - Business Wire
- 13 days ago - NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 15 days ago - NeoGenomics, Inc. (NEO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - NeoGenomics Reports Third Quarter 2024 Results - Business Wire
- 4 weeks ago - NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test - Business Wire
- 5 weeks ago - NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024 - Business Wire
- 6 weeks ago - NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia - Business Wire